Tag Archive | "Mitsubishi Tanabe"

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

Mitsubishi Tanabe

Tags: ,

Mitsubishi Tanabe is a top pharmaceutical company based in Tokyo, Japan Read the full story

Mitsubishi Tanabe Pharma in $357 million M&A deals with Medicago

Tags: , ,

Medicago entered M&A deals with Mitsubishi Tanabe Pharma whereby Mitsubishi Tanabe Pharma will acquire all of the issued and outstanding common shares of Medicago. Read the full story

Big pharma Mitsubishi Tanabe extends BioInvent antibody library licensing

Tags: , , ,

Mitsubishi Tanabe has entered big pharma deals with BioInvent for an extended licensing agreement in relation to their antibodies library. Read the full story

Mitsubishi Tanabe: Company Profile

Tags: ,

Mitsubishi Tanabe, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Mitsubishi Tanabe in pharma licensing with Dezima

Tags: , , , ,

Big pharma, Mitsubishi Tanabe has signed a pharma licensing agreement with Dezima Pharma with regards to the  in-licensing of a cholesteryl ester transfer protein inhibitor DEZ-001 Read the full story

Big Pharma, Mitsubishi Tanabe signs Fynomer discovery pharma deals with Covagen

Tags: , , , ,

Covagen admitted signing of two definitive pharma deals with Mitsubishi Tanabe, a top 50 pharma company and and its fully owned subsidiary Tanabe Research Laboratories for $146 million Read the full story

Mitsubishi Tanabe lenghthen pharma partners deal with Synageva BioPharma

Tags: , , ,

Synageva BioPharma announced an expansion of its previous pharma partners collaboration with Mitsubishi Tanabe Pharma to develop a second protein therapeutic for an undisclosed orphan disease using Synageva’s product development capabilities and proprietary protein expression platform.  Read the full story

Medicago gets C$3m up front from Mitsubishi Tanabe in vaccine deal

Tags: , ,

Mitsubishi Tanabe Pharma is paying Medicago C$3 million up front in a vaccine research agreement.  Read the full story

Nuron Biotech licenses HibTITER vaccine to Mitsubishi Tanabe for Japanese market

Tags: , , ,

Nuron Biotech has licensed its HibTITER vaccine to Mitsubishi Tanabe Pharma for commercialization in the Japanese market for both the single entity and for combination product use.  Read the full story